This efficacy differential highlights an important trade-off in the oral GLP-1 space: orforglipron offers the convenience of oral administration and freedom from injection but, based on current data, produces somewhat less weight loss than the most potent injectable multi-receptor agonists
Consult your healthcare provider before making medical decisions, especially if a reaction is new, worsening, recurrent, or concerning
These side effects, such as headaches, nausea, vomiting, stomach pain, heartburn, rash, insomnia (difficulty sleeping), increased liver enzymes, photosensitivity, irritation, dizziness, and tiredness, are usually not serious and will likely diminish over time
It is available in two strengths (5mg and 25mg) with dosing tailored to your cognitive goals, tolerance, and clinical history